Skip to main content

Table 3 Adjusted odds ratios of insulin resistance among those in the extreme quartiles of each evaluated variable

From: Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance

 

Men

Women

 

Model 1

Model 2

Model 3

Model 1

Model 2

Model 3

Lipid measures

TC

1.23 (0.99-1.52)

1.30 (1.06-1.61)

1.27 (1.03-1.57)

1.17 (0.96-1.44)

1.36 (1.11-1.66)

1.19 (0.97-1.47)

TG

2.78 (2.20-3.51)

2.86 (2.29-3.57)

2.92 (2.31-3.68)

2.70 (2.17-3.36)

3.36 (2.72-4.14)

2.88 (2.32-3.58)

LDL-C

1.13 (0.92-1.39)

1.09 (0.88-1.34)

1.19 (0.96-1.46)

1.13 (0.92-1.39)

1.17 (0.96-1.43)

1.13 (0.92-1.38)

Non-HDL-C

1.64 (1.31-2.05)

1.74 (1.40-2.16)

1.74 (1.40-2.17)

1.46 (1.18-1.81)

1.80 (1.47-2.21)

1.51 (1.22-1.87)

Apo B

1.55 (1.25-1.92)

1.61 (1.30-1.99)

1.59 (1.28-1.97)

1.69 (1.37-2.10)

2.01 (1.63-2.47)

1.69 (1.36-2.09)

HDL-C

0.52 (0.42-0.65)

0.50 (0.41-0.63)

0.49 (0.39-0.61)

0.66 (0.54-0.81)

0.55 (0.46-0.67)

0.64 (0.52-0.78)

Apo A-I

0.70 (0.57-0.86)

0.70 (0.57-0.86)

0.67 (0.54-0.82)

0.93 (0.77-1.13)

0.92 (0.76-1.11)

0.92 (0.76-1.12)

Lipid ratios

TC/HDL-C

2.14 (1.70-2.68)

2.22 (1.78-2.77)

2.31 (1.84-2.89)

1.87 (1.51-2.32)

2.38 (1.93-2.92)

1.97 (1.59-2.44)

TG/HDL-C

3.04 (2.40-3.85)

3.09 (2.47-3.87)

3.19 (2.53-4.04)

2.70 (2.17-3.36)

3.39 (2.75-4.17)

2.86 (2.30-3.56)

LDL-C/HDL-C

1.57 (1.26-1.95)

1.55 (1.25-1.92)

1.71 (1.38-2.12)

1.57 (1.28-1.93)

1.80 (1.47-2.19)

1.59 (1.29-1.95)

Non- HDL-C/HDL-C

2.14 (1.70-2.68)

2.22 (1.78-2.77)

2.31 (1.84-2.89)

1.87 (1.51-2.32)

2.38 (1.93-2.92)

1.97 (1.59-2.44)

Apo B/apo A-I

1.85 (1.49-2.31)

1.91 (1.54-2.37)

1.96 (1.58-2.43)

1.61 (1.31-1.98)

1.87 (1.53-2.28)

1.63 (1.33-2.01)

Visceral adiposity indicators

LAP

3.02 (2.39-3.81)

3.06 (2.45-3.82)

3.21 (2.52-4.08)

2.31 (1.79-2.98)

3.01 (2.38-3.81)

2.59 (2.07-3.23)

VAI

3.1 (2.35-4.07)

3.16 (2.43-4.18)

3.76 (2.7-5.24)

2.45 (1.98-3.05)

3.12 (2.54-3.82)

2.86 (2.13-3.84)

TyG index

5.58 (4.37-7.14)

5.29 (4.19-6.69)

5.74 (4.49-7.33)

5.18 (4.10-6.54)

5.91 (4.75-7.35)

5.37 (4.25-6.77)

  1. Model 1 was adjusted for age, rural/urban settings, region, education level, smoking status, alcohol use, body mass index, systolic blood pressure, uric acid, and hs-CRP. Model 2 was adjusted for all the variables in model 1 plus waist circumference.
  2. Model 3 was adjusted for body mass index, rural/urban settings, region, education level, alcohol use, and Framingham Risk Score (low, intermediate, and high).
  3. TC, total cholesterol; TG: triglycerides; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; Apo B: apolipoprotein B; Apo A-I: apolipoprotein A1; LAP: lipid accumulation product; VAI: visceral adiposity index; TyG index: the product of triglycerides and fasting glucose.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840